American Oncology Network, Inc. (NASDAQ:AONC) Short Interest Down 32.7% in March

American Oncology Network, Inc. (NASDAQ:AONC) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 20,400 shares, a drop of 32.7% from the February 29th total of 30,300 shares. Based on an average daily trading volume, of 9,500 shares, the days-to-cover ratio is presently 2.1 days. Approximately 0.8% of the shares of the company are sold short.

American Oncology Network Price Performance

Shares of NASDAQ AONC opened at $5.49 on Friday. American Oncology Network has a 12-month low of $4.78 and a 12-month high of $39.60. The firm’s 50 day simple moving average is $5.76.

Institutional Investors Weigh In On American Oncology Network

A hedge fund recently bought a new stake in American Oncology Network stock. Applied Capital LLC bought a new stake in shares of American Oncology Network, Inc. (NASDAQ:AONC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 37,499 shares of the company’s stock, valued at approximately $221,000.

American Oncology Network Company Profile

American Oncology Network, Inc, through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.